ALISON DELICH: Open Payments
NPI 1265811442 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$906 in 47 payments from 18 companies in 2025. Trend: 2023 $1,016 · 2024 $890 · 2025 $906
Food & beverage: $906
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $224 |
| ABBVIE INC. | 12 | $205 |
| PFIZER INC. | 5 | $82 |
| Lilly USA, LLC | 3 | $53 |
| SHIELD THERAPEUTICS INC | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Antares Pharma, Inc. | 2 | $36 |
| Amneal Pharmaceuticals LLC | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Novo Nordisk Inc | 1 | $20 |
Products named: AIRSUPRA, QULIPTA, UBRELVY, ELIQUIS, FARXIGA, ACCRUFER, REXULTI, VRAYLAR.
Industry payments across KS — which companies pay providers there.
